BANK OF AMERICA CORP /DE/ - PRONAI THERAPEUTICS INC ownership

PRONAI THERAPEUTICS INC's ticker is DNAI and the CUSIP is 74346L101. A total of 38 filers reported holding PRONAI THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PRONAI THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$13,000
-27.8%
8,575
-11.9%
0.00%
Q3 2016$18,000
-43.8%
9,730
-39.0%
0.00%
Q2 2016$32,000
-36.0%
15,941
+115.4%
0.00%
Q1 2016$50,000
-50.5%
7,400
+9.7%
0.00%
Q4 2015$101,000
+1342.9%
6,743
+1974.8%
0.00%
Q3 2015$7,0003250.00%
Other shareholders
PRONAI THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Hayman Capital 422,200$8,664,0004.00%
ADAMS STREET PARTNERS LLC 1,159,546$17,845,0003.79%
RA Capital Management 604,982$12,414,0001.78%
VHCP Management, LLC 250,000$5,130,0001.32%
CAXTON CORP 45,719$938,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,348,401$27,669,0001.07%
SECTORAL ASSET MANAGEMENT INC 862,766$17,290,0000.79%
Orbimed Advisors 1,989,949$40,834,0000.41%
Cormorant Asset Management, LP 53,153$1,091,0000.17%
DAFNA Capital Management LLC 8,500$174,0000.17%
View complete list of PRONAI THERAPEUTICS INC shareholders